Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
about
Structure of an agonist-bound human A2A adenosine receptorAdenosine receptors as therapeutic targetsAttenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats.A Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric OxideTargeting of adenosine receptors in ischemia-reperfusion injury.Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.Stimulation of A2A-adenosine receptors after myocardial infarction suppresses inflammatory activation and attenuates contractile dysfunction in the remote left ventricle.Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationCardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.2-Dialkynyl derivatives of (N)-methanocarba nucleosides: 'Clickable' A(3) adenosine receptor-selective agonists.Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactionsTaming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligandsPharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacy.Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.Cytotoxic Activity and Three-Dimensional Quantitative Structure Activity Relationship of 2-Aryl-1,8-naphthyridin-4-ones.Selective adenosine A receptor agonist, ATL-146e, attenuates stress-induced gastric lesions in rats.A New Class of Fluorinated A2A Adenosine Receptor Agonist with Application to Last-Step Enzymatic [18 F]Fluorination for PET Imaging.
P2860
Q24296388-66D86179-E38A-4549-95CC-A6253E6C539CQ24632095-04748A75-8209-4501-A7C9-3D1690985648Q28195202-3D8EF3D8-40D5-48A5-B1D8-6D6C04786955Q28550118-FB8F4C5F-F45F-4C5C-8C45-79996D838CA7Q30429069-DED06808-B650-4875-B807-E53ED3872234Q30437433-3380B02D-8E6D-4EDB-BAAE-922A01C403D9Q30438669-667CEF22-F5DD-4C36-98B0-E59939FC72A5Q30438880-6DC9FC15-AA41-4BD6-8B89-034DEA6E6F87Q30439172-026144A7-DF19-4E12-9493-DADDA75A4068Q30442968-69A3B78A-74BE-47A6-9158-894D1E2F75C7Q33638882-A5044FC6-A4D3-4CEC-9EEA-1C3AB18B6C0AQ35682331-9F2E89FB-9E46-4C2E-9D53-01B80F078E5EQ35987700-2B2A4049-26EE-4195-A3CA-D01B999256A3Q36183282-BCC5F446-2A68-4465-88FF-A5550F16A025Q37464148-B4C6E03B-5461-402A-B78E-A7C04E11BA43Q39190700-A9ED731E-C0FE-4DB8-8330-2C6898569727Q40798733-BF5C3867-FDFB-4358-9FE5-E755B4F7F9C7Q42064485-462964D2-2EFE-4C0F-9004-90D1EA812CC2Q45245816-190C988F-7199-4586-845A-ED96FBD36B07Q47888564-C8D69B5F-6C82-44BF-8265-15F3C7264AB4
P2860
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
@ast
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
@en
type
label
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
@ast
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
@en
prefLabel
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
@ast
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
@en
P2093
P356
P1476
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.
@en
P2093
P304
P356
10.1021/JM0003642
P407
P577
2001-02-01T00:00:00Z